APA (7th ed.) Citation

A, M., D, M., FS, K., Y, Z., JL, H., DE, E., . . . PH, B. (2012). The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice. Cancer prevention research (Philadelphia, Pa.), 5(10), 1195. https://doi.org/10.1158/1940-6207.CAPR-11-0524

Chicago Style (17th ed.) Citation

A, Mazumdar, Medina D, Kittrell FS, Zhang Y, Hill JL, Edwards DE, Bissonnette RP, and Brown PH. "The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-positive and ER-negative Mammary Tumors in P53-null Mammary Gland Mice." Cancer Prevention Research (Philadelphia, Pa.) 5, no. 10 (2012): 1195. https://doi.org/10.1158/1940-6207.CAPR-11-0524.

MLA (9th ed.) Citation

A, Mazumdar, et al. "The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-positive and ER-negative Mammary Tumors in P53-null Mammary Gland Mice." Cancer Prevention Research (Philadelphia, Pa.), vol. 5, no. 10, 2012, p. 1195, https://doi.org/10.1158/1940-6207.CAPR-11-0524.